SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001144204-16-141956
Filing Date
2016-12-30
Accepted
2016-12-30 17:02:10
Documents
10

Document Format Files

Seq Description Document Type Size
1 S-3 v455978_s3.htm S-3 367854
2 EXHIBIT 1.1 v455978_ex1-1.htm EX-1.1 183930
3 EXHIBIT 5.1 v455978_ex5-1.htm EX-5.1 14302
4 EXHIBIT 5.2 v455978_ex5-2.htm EX-5.2 7001
5 EXHIBIT 23.1 v455978_ex23-1.htm EX-23.1 2643
6 EXHIBIT 23.2 v455978_ex23-2.htm EX-23.2 2813
7 GRAPHIC line.gif GRAPHIC 43
8 GRAPHIC spacer.gif GRAPHIC 43
9 GRAPHIC logo_novavax.jpg GRAPHIC 39085
10 GRAPHIC pg1logo1_ex5-1.jpg GRAPHIC 6820
  Complete submission text file 0001144204-16-141956.txt   643313
Mailing Address 20 FIRSTFIELD ROAD GAITHERSBURG MD 20878
Business Address 20 FIRSTFIELD ROAD GAITHERSBURG MD 20878 240-268-2000
NOVAVAX INC (Filer) CIK: 0001000694 (see all company filings)

IRS No.: 222816046 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-215389 | Film No.: 162077964
SIC: 2836 Biological Products, (No Diagnostic Substances)